Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FH428
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,248
Award facts
- Contract value 100% obligated
- $56,248.07 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,248.07 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, with an ultimate completion date of the same day. This non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems.
This delivery order exemplifies Amerisourcebergen's role as a major federal pharmaceutical supplier, competing on a full and open basis without set-aside designations. The company's DLA IDC vehicle enables flexible fulfillment of pharmaceutical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The firm fixed-price delivery order structure demonstrates the company's capability to efficiently meet specific medical supply requirements while maintaining cost certainty for the government. DLA Troop Support Medical maintains strategic supplier diversity through its Pharmaceutical Prime Vendor Global Program Generation V initiative, which plans to establish multiple regional contracts with at least three different contractors to ensure robust supply chain resilience for military healthcare operations.
Quick answers
Who was awarded contract SPE2DU26FH428?
SPE2DU26FH428 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FH428 worth?
The government has obligated $56,248 on SPE2DU26FH428.
Is contract SPE2DU26FH428 an order under another contract?
Yes. SPE2DU26FH428 is a delivery order under SPE2DU25D4116, an indefinite delivery contract.
Was contract SPE2DU26FH428 competed?
The extent of competition for SPE2DU26FH428 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award